| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |